Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hormesis and risk assessment.

Karl K Rozman1

  • 1Department of Pharmacology, Toxicology, and Therapeutics, University of Kansas Medical Center, 1018 Breidenthal Building, Mail Stop 1018, 3901 Rainbow Boulevard, Kansas City, KS 66160-7417, USA. krozman@kumc.edu

Human & Experimental Toxicology
|July 12, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Endocrine disruption: fact or urban legend?

Toxicology letters·2013
Same author

From more to less than Haber's law.

Environmental toxicology and pharmacology·2011
Same author

2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) reverses hyperglycemia in a type II diabetes mellitus rat model by a mechanism unrelated to PPAR gamma.

Drug and chemical toxicology·2010
Same author

Letter to the editor regarding Bailey article.

Chemical research in toxicology·2009
Same author

Relationship between aryl hydrocarbon receptor-affinity and the induction of EROD activity by 2,3,7,8-tetrachlorinated phenothiazine and derivatives.

Toxicology and applied pharmacology·2007
Same author

From dioxin to drug lead--the development of 2,3,7,8-tetrachlorophenothiazine.

ChemMedChem·2007
Same journal

Establishment of a rat model of bronchopulmonary dysplasia complicated with pulmonary hypertension and its potential applications.

Human & experimental toxicology·2026
Same journal

Pulmonary iron oxide (Fe<sub>3</sub>O<sub>4</sub>) nanoparticle-biomolecule interactions modified during aging and metabolic syndrome disease progression.

Human & experimental toxicology·2026
Same journal

Retraction: Carvedilol alleviates the detrimental effects of azathioprine on hepatic tissues in experimental rats: Focusing on redox system, inflammatory and apoptosis pathways.

Human & experimental toxicology·2026
Same journal

Inhibition of store-operated calcium entry mitigates lipopolysaccharide-induced hepatotoxicity via modulating inflammatory and oxidative stress responses.

Human & experimental toxicology·2026
Same journal

Stevioside inhibits colorectal cancer progression by regulating macrophage polarization.

Human & experimental toxicology·2026
Same journal

Predictive factors of severe outcome in glufosinate ammonium poisoning: A retrospective study in Vietnam.

Human & experimental toxicology·2025
See all related articles

This study proposes that low chemical doses yield beneficial effects, while high doses are toxic. A mathematical model using beta-curves can identify safe exposure levels for risk assessment.

Area of Science:

  • Toxicology
  • Pharmacology
  • Biostatistics

Background:

  • The dose-response relationship is fundamental in toxicology.
  • Paracelsus established that high chemical doses are toxic.
  • Hormesis describes beneficial effects at low doses.

Purpose of the Study:

  • To postulate beneficial effects of low chemical doses.
  • To describe the combined low and high dose effects using a beta-curve.
  • To propose a mathematical method for risk assessment.

Main Methods:

  • Empirical description of dose-response curves.
  • Application of beta-curve and inverted beta-curve models.
  • Mathematical determination of curve extrema for risk assessment.

Related Experiment Videos

Main Results:

  • All chemicals exhibit hormetic effects at low doses.
  • A beta-curve or inverted beta-curve can model these effects.
  • A method to determine optimal dose points was suggested.

Conclusions:

  • Low-dose hormesis is a universal phenomenon.
  • Beta-curve modeling provides a framework for understanding chemical effects.
  • The proposed mathematical method aids in chemical risk assessment.